Regeneration in Practice: Engineering the Future of Healthcare

• How engineered tissues, gene-edited cells, and immune-modulating signals work together to drive functional regeneration

• The scientific, manufacturing, and regulatory challenges of translating complex, biology-driven therapies into clinical practice

• What founders, clinicians, and investors need to understand about building scalable, durable regenerative healthcare solutions

Shayn Peirce-Cottler – Session Moderator
Professor and Chair, Biomedical Engineering
University of Virginia

Stephen Kennedy
Head of Technical Operations
CRISPR Therapeutics

Ben Holmes
CEO
Nanochon

Don Griffin
Chief Scientific Officer
Tempo Therapeutics